Volume No. :   8

Issue No. :  3

Year :  2018

ISSN Print :  2231-5705

ISSN Online :  2231-5713


Registration

Allready Registrered
Click to Login

Formulation and Evaluation of Orodispersible Tablet of Naratriptan HCl



Address:   Renuka S. Deshmukh*, Mr. M. M. Bari, Dr. S. D. Barhate
Department of Pharmaceutics, Shree Sureshdada Jain Institute of Pharmaceutical Education and Research,
Jamner -424206, Maharashtra, India.
*Corresponding Author
DOI No: 10.5958/2231-5713.2018.00022.3

ABSTRACT:
The aim of the study was to prepare and evaluate orodispersible tablet of antimigraine drug naratriptan HCl which is highly appropriate as it has ease of administration for mentally ill, disabled and uncooperative patients. The ODT’s were prepared by direct compression method using croscarmellose sodium & crospovidone as superdisintegrants. There were no drug excipient interaction observed by FTIR & DSC. The drug & excipient were compatible with each other. Finally it was concluded that F5 batch prepared by using 2.5% w/w croscarmellose sodium showed 99.98% release of drug over a period of 15 min. while D.T 26 seconds. It passes dispersibility test also F5 batch was also compared with marketed tablets of naratriptan HCl F5 batch showed better release of drug as compared to marketed tablet.
KEYWORDS:
Naratriptan HCl, ODT, Croscarmellose sodium, Crospovidone, Direct compression.
Cite:
Renuka S. Deshmukh, M. M. Bari, S. D. Barhate. Formulation and Evaluation of Orodispersible Tablet of Naratriptan HCl. Asian J. Pharm. Tech. 2018; 8 (3):139-144 .
[View HTML]     



Visitor's No. :   116234